The company filed a lawsuit Wednesday in the US District Court for the District of Columbia challenging certain aspects of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program, as well as the guidance issued by the Centers for Medicare & Medicaid Services implementing the law.
The program allows the US government to set the prices on some of the most widely used and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.